Bronchial Asthma
Conditions
Interventions
None listed
Sponsors
National Hospital Organization Sagamihara National Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have inhaled corticosteroids or corticosteroids-long-acting beta-2 adrenergic agonist combinations using a device with a dose counter.
Exclusion criteria
Exclusion criteria: 1) It is impossible to measure lung function. 2) Patient has had an attack that required the inhalation of beta-2 adrenergic agonists to relieve symptoms within 2 weeks prior to the start of the trial. 3) Patients who did not agree to participate in the study. 4) The subject is deemed inappropriate for this study, as judged by a medical doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients will be divided into 2 groups, where drug adherence rate is more than 70% or less than 70%, and the following objective index will be compared between them. 1.The parameters of spirometry 2.Bronchodilator response | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Comparison of adherence between self-report and the remaining number of a dose counter 2. Compare following indices between 2groups. a)Exhaled NO b)The airway resistance with Forced Oscillation Technique 3.Reevaluation of the objective indices in the group whose drug adherence rate was less than 70% three months later. The majority of them had received education on the role of inhaled steroids and confirmation of effective inhaler technique. | — |
Countries
Japan
Contacts
Public ContactTetsuharu Manabe
National Hospital Organization Sagamihara National Hospital Department of Pediatrics
Outcome results
None listed